Aminoglycoside-associated severe renal failure in patients with multiple myeloma treated with thalidomide

被引：14
|
作者：
Montagut, C [1 ]
Bosch, F [1 ]
Villela, L [1 ]
Rosiñol, L [1 ]
Bladé, J [1 ]
机构：
[1] Univ Barcelona, Hosp Clin, IDIBAPS, ICMHO,Dept Hematol, E-08036 Barcelona, Spain
来源：
LEUKEMIA & LYMPHOMA | 2004年 / 45卷 / 08期
关键词：
multiple myeloma; thalidomide; aminoglycoside; renal failure;
D O I：
10.1080/10428190310001638841
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Thalidomide has been proved to play an important role in rescue treatment of patients with refractory/relapsed multiple myeloma (MM). However, thalidomide therapy is associated with numerous side effects, mainly somnolence, constipation, fatigue or peripheral neuropathy. We report three patients diagnosed with MM and treated with thalidomide as salvage therapy who developed severe renal failure when they received aminoglycoside antibiotics. This observation suggests that thalidomide can potentiate nephrotoxicity of aminoglycoside antibiotics in patients with MM.
引用
收藏
页码：1711 / 1712
页数：2
相关论文
共 50 条
  • [21] Low incidence of thromboembolism in Korean patients with multiple myeloma treated with thalidomide
    Koh, Y.
    Bang, S.
    Lee, J.
    Yoon, H.
    Do, Y.
    Ryoo, H.
    Lee, N.
    Kim, S.
    Kim, K.
    Kim, H.
    Yoon, S.
    Won, J.
    Mun, Y.
    Lee, M.
    Rhee, K.
    Eom, H.
    Kim, M.
    Shin, H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1100 - 1101
  • [22] FREQUENCY OF CYTOKINE PRODUCING MONOCYTES IN PATIENTS WITH MULTIPLE MYELOMA TREATED WITH THALIDOMIDE
    Filipe, S.
    Matos, A.
    Morgado, J. M.
    Silva, I.
    Inacio, M. J.
    Geraldes, C.
    Paiva, A.
    Pais, M. L.
    Teixeira, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 512 - 512
  • [23] Aminoglycoside-associated acute kidney injury in elderly patients with and without shock
    Ong, Li-Zhen
    Tambyah, Paul A.
    Lum, Lionel H.
    Low, Zhen-Jie
    Cheng, Ivy
    Murali, Tanusya M.
    Wan, Mei-Qi
    Chua, Horng-Ruey
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (11) : 3250 - 3257
  • [24] Risk of renal failure associated with IV bisphosphonate use in patients with multiple myeloma
    Joyce, A. T.
    Harrison, D. J.
    Jun, S.
    Feliu, A. L.
    Anthony, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [25] Presentation and survival of patients with severe renal failure and myeloma
    Irish, AB
    Winearls, CG
    Littlewood, T
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 1997, 90 (12) : 773 - 780
  • [26] MULTIPLE-MYELOMA WITH RENAL-FAILURE TREATED BY DIALYSIS
    VIALTEL, P
    ELSENER, M
    MALLARET, MR
    ROUGIER, D
    MICHALLET, M
    DECHELETTE, E
    DENIS, MC
    CORDONNIER, D
    LYON MEDICAL, 1980, 244 (16): : 213 - 217
  • [27] Thalidomide and thrombosis in patients with multiple myeloma
    Camba, L
    Peccatori, J
    Pescarollo, A
    Tresoldi, M
    Corradini, P
    Bregni, M
    HAEMATOLOGICA, 2001, 86 (10) : 1108 - 1109
  • [28] Renal failure (RF) in multiple myeloma (MM) - Possible association with pamidronate and thalidomide.
    Yudis, M
    Sirota, RA
    Stein, HD
    Snipes, ER
    Gronich, JH
    Ghantous, VE
    Collins, DM
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 733A - 734A
  • [29] Thalidomide in elderly patients with multiple myeloma
    Kusumi, Eiji
    Matsumura, Tomoko
    Yuji, Koichiro
    Tanaka, Yuji
    Kami, Masahiro
    LANCET, 2006, 367 (9527): : 1977 - 1977
  • [30] Thalidomide/Dexamethasone Induction Therapy in Newly Diagnosed Myeloma Patients with Renal Failure
    Tosi, P.
    Tacchetti, P.
    Zamagni, E.
    Tacchetti, P.
    Ceccolini, M.
    Perrone, G.
    Brioli, A.
    Pallotti, M. C.
    Petrucci, A.
    Baccarani, M.
    Cavo, M.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S30 - S30
12345